Calliditas Therapeutics AB (publ) (CALT) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
025M50M75M100M125M150M175M200MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Operating Expenses

Research And Development ExpensesSelling And Marketing ExpensesGeneral And Administrative Expenses
09M18M26M35M44M52M61M70MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

EBITDA

EBITDA
-30M-26M-22M-17M-13M-9M-4M-250K4MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

EPS

Revenue Variation (%)

Revenue Variation
-40-10205080110140170200Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
02505007501K1K2K2K2KQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Revenue YoY Variation (%)

Revenue YoY Variation
050100150200250300350400Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
03757501K2K2K2K3K3KQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Price-to-Earning Ratio

P/E Ratio
-200-175-150-125-100-74-49-241Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0750K2M2M3M4M4M5M6MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000111222Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0500K1M2M2M2M3M4M4MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Free Cash Flow

Cash At End Of Period
025M50M75M100M125M150M175M200MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
04M8M11M15M19M22M26M30MQ2 2023Q3 2023Q4 2023Q1 2024Q2 2024
🏦 Balance Sheet
📈 Key Metrics